Co-induction Technique Compared to Standard Inhalational and Intravenous Induction Techniques
A Novel Co-induction Technique Compared to Standard Inhalational and Intravenous Induction Techniques: a Prospective Randomized Control Study
調査の概要
状態
詳細な説明
Co-induction technique refers to the use of a combination of medications to reach the desired therapeutic target. This technique is considered an approach that can be of a great benefit to patients with chronic medical illnesses and those who have moderate to high risk for general anaesthesia.
In the present study, the investigators examined the safety of a novel co-induction approach that relied on a simple timing and dosing alterations to the classical approaches of inhalational sevoflurane and propofol induction. The significance of this study is to find a reliable safe alternative method of induction that can provide optimal parameters,when compared to the classical methods of induction. The investigators evaluated the time needed for laryngeal mask airway (LMA) insertion, number of LMA insertion trials, succession of LMA insertion, adverse events related to the airway, respiratory and cardiovascular systems, haemodynamic stability and satisfaction scores of enrolled patients.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
-
Amman、ヨルダン、11942
- Jordan University Hospital
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- patients with Age ≥ 65 years.
- American Society of Anaesthesiologists' (ASA) score II or III.
- minimally invasive endoscopic urological procedures.
Exclusion Criteria:
- patient refusal.
- Age < 65 years.
- family history of malignant hyperthermia.
- prolonged surgery that needed intubation.
- body mass index (BMI) > 35 kg/m2.
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：防止
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：なし（オープンラベル）
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：Group P
Patient received a dose of 1.5 mg/kg of Propofol slowly over 2 minutes for induction.
|
Patients were given 1.5 mcg/Kg of fentanyl intravenously.
two minutes after the fentanyl dose, a dose of 1.5 mg/kg of propofol slowly over 2 minutes.
|
|
実験的：Group S
Patient received 8% sevoflurane through sealed plastic facemask at 8 L/min flow of oxygen.
|
Patients were given 1.5 mcg/Kg of fentanyl intravenously.
two minutes after the fentanyl dose, patient received 8% inhalational sevoflurane through sealed plastic face mask at 8 L/min flow of oxygen.
|
|
実験的：Group C
Patient received 4% sevoflurane through sealed plastic facemask at 8 L/min flow of oxygen for 2 minutes, followed by a dose of 0.75 mg/kg of propofol given slowly.
|
Patients were given 1.5 mcg/Kg of fentanyl intravenously.
two minutes after the fentanyl dose, patient received 4% sevoflurane through sealed plastic face mask at 8 L/min flow of oxygen for 2 minutes, followed by a dose of 0.75 mg/kg of propofol given slowly.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Intraoperative respiratory adverse events
時間枠：8 months
|
The investigators recorded the occurrence of transient apnea intraoperatively, in addition to laryngeal spasm, coughing, gagging and increased salivation.
The study chart included the documentation these common adverse events, the timing of occurrence, and the intervention required to manage these events.
|
8 months
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Time for successful laryngeal mask airway insertion
時間枠：8 months
|
The investigators assessed the time needed for LMA insertion.
The timer was started upon giving the fentanyl, recording the time till successful insertion of laryngeal mask airway.
|
8 months
|
|
Blood pressure stability
時間枠：8 months
|
The investigators recorded patients' blood pressure readings throughout the induction procedure.
|
8 months
|
|
Heart rate stability
時間枠：8 months
|
The investigators recorded patients' heart rate throughout the induction procedure.
|
8 months
|
|
Changes in oxygen saturation
時間枠：8 months
|
The investigators recorded patients' oxygen saturation throughout the induction procedure.
|
8 months
|
協力者と研究者
スポンサー
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。